Safety and Pharmacokinetics Study in Adults for the Prevention of S. Epidermidis Infection in Low Birth Weight Infants
Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase 1 study is to evaluate the safety and pharmacokinetics of BSYX-A110
in a small number of healthy adult volunteers. Following the demonstration of safety in
adults, this anti-Staphylococcal monoclonal antibody will then be evaluated in the target
population of hospitalized low birth weight neonates.